Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AHR-15010--a novel anti-arthritic agent.

J C Nolan1, D A Walsh, Y Lo

  • 1A. H. Robins Company, Department of Pharmacology, Richmond, VA 23220.

The Journal of Pharmacy and Pharmacology
|August 1, 1990
PubMed
Summary

A novel compound, AHR-15010, demonstrates significant anti-arthritic and anti-inflammatory effects in rat models. Its unique mechanism, distinct from common anti-inflammatories, involves carbonic anhydrase inhibition for potential arthritis treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large-scale molecular endotype discovery in synovial fluid reveals osteoarthritis as a single biological continuum.

Nature communications·2026
Same author

The association of painful and non-painful morbidities with frailty: a cross sectional analysis of a cohort of community dwelling older people in England.

BMC geriatrics·2024
Same author

Osteoarthritis Bone Marrow Lesions.

Osteoarthritis and cartilage·2022
Same author

Harmonising knee pain patient-reported outcomes: a systematic literature review and meta-analysis of Patient Acceptable Symptom State (PASS) and individual participant data (IPD).

Osteoarthritis and cartilage·2022
Same author

Time course and localization of nerve growth factor expression and sensory nerve growth during progression of knee osteoarthritis in rats.

Osteoarthritis and cartilage·2022
Same author

The osteoarthritis bone score (OABS): a new histological scoring system for the characterisation of bone marrow lesions in osteoarthritis.

Osteoarthritis and cartilage·2022

Area of Science:

  • Pharmacology
  • Immunology
  • Biochemistry

Background:

  • Adjuvant arthritis is a rat model used to study inflammatory joint diseases.
  • Current treatments for arthritis often have limitations or side effects.
  • Novel therapeutic agents with unique mechanisms are needed for effective arthritis management.

Purpose of the Study:

  • To investigate the anti-arthritic potential of AHR-15010, a compound with a novel chemical structure.
  • To elucidate the mechanism of action of AHR-15010 in inflammatory conditions.
  • To explore AHR-15010 as a potential therapeutic agent for arthritis.

Main Methods:

  • Oral administration of AHR-15010 to rats with adjuvant-induced arthritis.
  • Assessment of anti-inflammatory activity using X-ray analysis of hind paw lesions.

Related Experiment Videos

  • Evaluation of acute anti-inflammatory, analgesic, and hypersensitivity responses in various assays.
  • Biochemical assays to determine prostaglandin synthetase inhibition and carbonic anhydrase activity.

    • Main Results:

    • AHR-15010 significantly reduced inflammation and joint lesion severity in adjuvant arthritis models.
    • The compound exhibited no acute anti-inflammatory, analgesic, or hypersensitivity activity.
    • AHR-15010 does not inhibit prostaglandin synthetase but acts as a carbonic anhydrase inhibitor.
    • Acetazolamide, a known carbonic anhydrase inhibitor, shares potential therapeutic pathways with AHR-15010.

    Conclusions:

    • AHR-15010 possesses unique anti-arthritic properties, suggesting a novel mechanism of action.
    • Carbonic anhydrase inhibition is identified as a key mechanism for AHR-15010's therapeutic effects.
    • AHR-15010 and acetazolamide represent promising avenues for developing new arthritis treatments.